GlassScriptPhysician profile
David J Willard
NPI 1629457981
$1,840.07
in general payments reported to CMS, 2019-2025
24 companies · $971 in 2025
The $971 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.78 · 2024: $848 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.85 |
| Education | $164.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $255.68 | 2024-2025 | Repatha, Krystexxa, Repatha |
| Novartis Pharmaceuticals Corporation | $204.78 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $175.31 | 2025 | |
| Medtronic, INC. | $166.21 | 2025 | Plasmablade(Tm) |
| Baxter Healthcare | $159.80 | 2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Abiomed | $108.56 | 2024 | Impella |
| Teleflex LLC | $106.57 | 2024 | Urolift |
| E.R. Squibb & Sons, L.L.C. | $105.48 | 2025 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $84.48 | 2025 | Evkeeza |
| Merck Sharp & Dohme LLC | $68.86 | 2023-2025 | Verquvo |
| Edwards Lifesciences Corporation | $66.28 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $61.27 | 2025 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $43.95 | 2025 | Opsynvi, Opsumit, Uptravi |
| Heartflow, INC. | $35.61 | 2025 | |
| Boston Scientific Corporation | $27.15 | 2024 | Watchman Flx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $26.25 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.79 | 2024 | Jardiance |
| Exact Sciences Corporation | $23.84 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $20.37 | 2024 | Xarelto |
| Janssen Scientific Affairs, LLC | $16.51 | 2024 | Xarelto |
| Ionis Pharmaceuticals, INC. | $16.07 | 2025 | Tryngolza |
| Esperion Therapeutics, INC. | $16.01 | 2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $15.37 | 2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.87 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Willard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.